Skip to main navigation
  • Skip to content
  • Skip to primary sidebar
Back to the Corporate Site
Veloxis

Back to the Corporate Site

Investor Relations

IR Menu

  • News & Releases
  • Download Center
  • Calendar
  • Corporate Governance
    • Governance Documents
    • Risk Management
    • Reporting Compliance
    • Violations and Concerns
    • Whistleblower Policy
    • Whistleblowing Guidelines
  • Financial Information
    • Outlook
  • Stock Information
    • Historic Stock Lookup
    • Investment Calculator
    • Order Depth and Latest Trades
    • Analyst Coverage
  • General Meetings

Governance Documents

Governance Documents

Governance Statements
Statutory Corporate Governance Report for 2017, cf. art. 107b of the Danish Financial Statements Act 718.5 KB
Statutory statement of corporate governance, cf. section 107b of the Danish Financial Statements Act (2016) 681.6 KB
Statutory statement of corporate governance, cf. section 107b of the Danish Financial Statements Act (2015) 496.8 KB
Statutory statement of corporate governance, cf. section 107b of the Danish Financial Statements Act (2014) 500.2 KB
Statutory statement of corporate governance, cf. section 107b of the Danish Financial Statements Act (2013) 401.4 KB
Veloxis Corporate Governance 2011 - English 518.5 KB
Veloxis Corporate Governance 2011 - Danish 421.9 KB
Statutory statement of corporate governance, cf. section 107b of the Danish Financial Statements Act (2012) 671.1 KB
Lovpligtig redegørelse for virksomhedsledelse, jf. årsregnskabslovens § 107b (2012) 840.3 KB
Statutory statement of corporate governance, cf. section 107b of the Danish Financial Statements Act (2011) 694.7 KB
Lovpligtig redegørelse for virksomhedsledelse, jf. årsregnskabslovens § 107b (2011) 565.3 KB
Statutory statement of corporate governance, cf. section 107b of the Danish Financial Statements Act (2012) 500.9 KB
US Compliance Statements
Code of Business Conduct 866.5 KB
US Compliance Statements

To request a summary of the Veloxis Comprehensive Compliance Program, please call +1 919 591 3090.
272.2 KB
Documents
Articles of Association 667.5 KB
Vedtægter 454.8 KB
Audit Committee Charter 398.2 KB
Remuneration Policy 143.9 KB
IR Policy 173.6 KB
Efforts by Veloxis to Obtain Final Approval for Envarsus® XR from the Food and …
Vederlagspolitik 220.5 KB
Remuneration Committee Charter 82.8 KB
Vedtægter 497.9 KB
Rules of Procedure for the Board of Directors 198.9 KB

Submenu - Corporate Governance

  • Corporate Governance
  • Governance Documents
  • Risk Management
  • Reporting Compliance
  • Violations and Concerns
  • Whistleblower Policy
  • Guidelines for Reported Employees

Shareholder Portal

Enter Veloxis portal for existing shareholders.

flagDA  PÅ DANSK flagUK  IN ENGLISH

Latest News & Releases

Jan 03, 2019
Mark Hensley Promoted to Chief Commercial Officer of Veloxis Pharmaceuticals
Dec 31, 2018
Veloxis Pharmaceuticals A/S Grants Warrants Under Existing Warrant Program

View All

© 2019 All rights reserved. Veloxis Pharmaceuticals Inc. ENV-18-090.0 06/18

info@veloxis.com | 1-844-VELOXIS (835-6947), Monday-Friday, 9AM-7PM ET

Sitemap | Contact | Privacy Policy | Disclaimer